Core Cap Advisors, LLC Sorrento Therapeutics, Inc. Transaction History

Core Cap Advisors, LLC

  • $2.07 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$0.74 - $1.83 $2,072 - $5,125
2,801 New
2,801 $2,000
Q2 2022

Aug 11, 2022
BUY
$1.24 - $2.33 $3,473 - $6,526
2,801 New
2,801 $6,000
Q1 2022

Apr 29, 2022
SELL
$2.0 - $4.9 $5,602 - $13,724
-2,801 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$4.65 - $7.23 $13,024 - $20,251
2,801 New
2,801 $13,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email